HRS9531 Tablet

· Fujian Shengdi Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HRS9531 Tablet, covering 2026-04-03 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of HRS9531 Tablet in Obese Subjects [Phase 2]